Sex: M
Vaccine: RAB
Symptoms: Incomplete course of vaccination
Clinical narrative: For this vaccine it says there should be 5 injections, however when we initially got the vaccine for post exposure we got 4 injections; Case reference number US-BN-2021-002327 is a spontaneous case report initially received from a consumer via Agency (reference number: USBAV21-0515) on 7-Oct-2021 and concerns a male patient.   The patients' medical history and concomitant medication details were not provided.  On unspecified date, reported as couple of years ago, the patient was vaccinated with the first dose of RabAvert (Inactivated Rabies Virus Vaccine, batch number was not provided) at unknown dose, at unknown route or site of administration, for post-exposure prophylaxis.  On unspecified date, reported as couple of years ago, the patient was vaccinated with the second dose of RabAvert (Inactivated Rabies Virus Vaccine, batch number was not provided) at unknown dose, at unknown route or site of administration, for post-exposure prophylaxis.  On unspecified date, reported as couple of years ago, the patient was vaccinated with the third dose of RabAvert (Inactivated Rabies Virus Vaccine, batch number was not provided) at unknown dose, at unknown route or site of administration, for post-exposure prophylaxis.  On unspecified date, reported as couple of years ago, the patient was vaccinated with the fourth dose of RabAvert (Inactivated Rabies Virus Vaccine, batch number was not provided) at unknown dose, at unknown route or site of administration, for post-exposure prophylaxis (Incomplete course of vaccination).  On 04-Oct-2021, the patient was vaccinated with the booster dose of RabAvert (Inactivated Rabies Virus Vaccine, batch number was not provided) at a dose reported as one vaccine per dose, at unknown route or site of administration, for post-exposure prophylaxis.  On 07-Oct-2021, the patient was vaccinated with the booster dose of RabAvert (Inactivated Rabies Virus Vaccine, batch number was not provided) at a dose reported as one vaccine per dose, at unknown route or site of administration, for post-exposure prophylaxis.  The reporter stated that the patient was initially administered with only four injections for post exposure. It was reported that the four injections were administered a couple of years ago. (explicitly coded as Incomplete course of vaccination).   The reporter also stated that the patient received two booster doses, first on 04-Oct-2021 and second on 07-Oct-2021. The reporter stated that the first booster vaccine was a little pink prior to administration. The reporter stated that the patient tended to run fever with vaccines.  The reporter assessed the case as not related to RabAvert vaccine.  The reporter did not provide seriousness criteria.  Case is linked with US-BN-2021-002326 (same reporter).  Minor case correction was performed on 14-Oct-2021 included the Agency local case ID: BN_2021_00114.  No further information was provided.; Reporter's Comments: Incomplete course of vaccination is listed per convention. On unspecified date, reported as couple of years ago, the patient started vaccination with RabAvert vaccine for post-exposure prophylaxis. The reporter stated that the patient was initially administered with only four injections for post-exposure prophylaxis, which is considered incomplete course of vaccination. Incomplete course of vaccination is not related to the suspect vaccine, but to a human action. This case is non-serious.; Sender's Comments: Incomplete course of vaccination is listed per convention. On unspecified date, reported as couple of years ago, the patient started vaccination with RabAvert vaccine for post-exposure prophylaxis. The reporter stated that the patient was initially administered with only four injections for post-exposure prophylaxis, which is considered incomplete course of vaccination. Incomplete course of vaccination is not related to the suspect vaccine, but to a human action. This case is non-serious.